Movatterモバイル変換

[0]ホーム
URL:

Jump to content
WikipediaThe Free Encyclopedia
Search

Mexrenone

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Mexrenone
Clinical data
Other namesZK-32055; SC-25152; 7α-(Methoxycarbonyl)canrenone;17β-Hydroxy-3-oxo-17α-pregn-4-ene-7α,21-dicarboxylic acid γ-lactone methyl ester
Identifiers
  • methyl (7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-carboxylate
CAS Number
PubChemCID
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC24H32O5
Molar mass400.515 g·mol−1
3D model (JSmol)
  • COC(=O)[C@@H]4C\C1=C\C(=O)CC[C@]1(C)[C@H]5CC[C@@]3(C)[C@@H](CC[C@]23CCC(=O)O2)[C@H]45
  • InChI=1S/C24H32O5/c1-22-8-4-15(25)12-14(22)13-16(21(27)28-3)20-17(22)5-9-23(2)18(20)6-10-24(23)11-7-19(26)29-24/h12,16-18,20H,4-11,13H2,1-3H3/t16-,17+,18+,20-,22+,23+,24-/m1/s1
  • Key:ADZYJDJNIBFOQE-RGKMBJPFSA-N

Mexrenone (code namesZK-32055,SC-25152) is asteroidalantimineralocorticoid of thespirolactone group related tospironolactone that was never marketed.[1][2] It is thelactonic form ofmexrenoic acid (mexrenoate), andmexrenoate potassium (SC-26714), thepotassiumsalt of mexrenoic acid, also exists.[3] In addition to themineralocorticoid receptor, mexrenone also binds to theglucocorticoid,androgen, andprogesterone receptors.[4] Relative to spironolactone, it has markedly reducedantiandrogen activity (approximately one-tenth of the antimineralocorticoid dosage equivalent antiandrogen activity of spironolactone).[2]Eplerenone is the 9-11α-epoxyanalogue of mexrenone.[5]

See also

[edit]

References

[edit]
  1. ^Cutler GB, Pita JC, Rifka SM, Menard RH, Sauer MA, Loriaux DL (July 1978). "SC 25152: A potent mineralocorticoid antagonist with reduced affinity for the 5 alpha-dihydrotestosterone receptor of human and rat prostate".The Journal of Clinical Endocrinology and Metabolism.47 (1):171–175.doi:10.1210/jcem-47-1-171.PMID 263288.
  2. ^abCutler GB, Sauer MA, Loriaux DL (April 1979). "SC 25152: a potent mineralocorticoid antagonist with decreased antiandrogenic activity relative to spironolactone".The Journal of Pharmacology and Experimental Therapeutics.209 (1):144–146.doi:10.1016/S0022-3565(25)31630-7.PMID 430374.
  3. ^Hofmann LM, Weier RM, Suleymanov OD, Pedrera HA (June 1977). "Mexrenoate potassium: a steroidal aldosterone antagonist and antihypertensive".The Journal of Pharmacology and Experimental Therapeutics.201 (3):762–768.doi:10.1016/S0022-3565(25)30916-X.PMID 864608.
  4. ^Szasz G, Budvari-Barany Z (19 December 1990).Pharmaceutical Chemistry of Antihypertensive Agents. CRC Press. pp. 87–.ISBN 978-0-8493-4724-5.
  5. ^Ménard J (March 2004). "The 45-year story of the development of an anti-aldosterone more specific than spironolactone".Molecular and Cellular Endocrinology.217 (1–2):45–52.doi:10.1016/j.mce.2003.10.008.PMID 15134800.S2CID 19701784.
ARTooltip Androgen receptor
Agonists
SARMsTooltip Selective androgen receptor modulator
Antagonists
GPRC6A
Agonists
MRTooltip Mineralocorticoid receptor
Agonists
Antagonists

This article about apregnanes is astub. You can help Wikipedia byexpanding it.

Stub icon

Thisdrug article relating to thecardiovascular system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Mexrenone&oldid=1323777240"
Categories:
Hidden categories:
[8]ページ先頭
©2009-2025 Movatter.jp